Immune response in hamsters immunised with a recombinant fragment of LigA from Leptospira interrogans, associated with carrier molecules

Memorias do Instituto Oswaldo Cruz

Volumn 111, Issue 11, 2016, Pages 712-716

  Oliveira, Thaís L ^a   Bacelo, Kátia L ^a   Schuch, Rodrigo A ^a   Seixas, Fabiana K ^a   Collares, Tiago ^a   Rodrigues, Oscar E D ^b   Vargas, Josimar ^b   do Nascimento, Rafaella O ^c   Dellagostin, Odir A ^a   Hartwig, Daiane D ^a  

^a FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Carrier molecules; Leptospira; LigANI

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BACTERIAL VACCINE; BACTERIUM ANTIBODY; CARBON NANOTUBE; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; RECOMBINANT PROTEIN; SUBUNIT VACCINE;

ANIMAL; BLOOD; CHEMISTRY; HAMSTER; HUMORAL IMMUNITY; IMMUNOLOGY; LEPTOSPIRA INTERROGANS; LEPTOSPIROSIS; MESOCRICETUS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL VACCINES; CRICETINAE; IMMUNITY, HUMORAL; IMMUNOGLOBULIN G; LEPTOSPIRA INTERROGANS; LEPTOSPIROSIS; MESOCRICETUS; NANOTUBES, CARBON; RECOMBINANT PROTEINS; VACCINES, SUBUNIT;

EID: 84994627565     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/0074-02760160214     Document Type: Article

References (39)

1. Adler B. Vaccines against leptospirosis. Curr Top Microbiol Immunol. 2015; 387: 251-72.
2. Bacelo KL, Hartwig DD, Seixas FK, Schuch R, Moreira AS, Amaral M, et al. Xanthan gum as an adjuvant in a subunit vaccine preparation against leptospirosis. Biomed Res Int. 2014; 2014: 636491.
3. Bhirde AA, Patel V, Gavard J, Zhang G, Sousa AA, Masedunskas A, et al. Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery. ACS Nano. 2009; 3(2): 307-16.
4. Bianco A, Hoebeke J, Godefroy S, Chaloin O, Pantarotto D, Briand JP, et al. Cationic carbon nanotubes bind to CpG oligodeoxynucleotides and enhance their immunostimulatory properties. J Am Chem Soc. 2005; 127(1): 58-9.
5. Bode C, Zhao G, Steinhagen F, Kinjo T, Klinman DM. CpG DNA as a vaccine adjuvant. Expert Rev Vaccines. 2011; 10(4): 499-511.
6. Burnette WN. Recombinant subunit vaccines. Curr Opin Biotechnol. 1991; 2(6): 882-92.
7. Chiou CJ, Tseng LP, Deng MC, Jiang PR, Tasi SL, Chung TW, et al. Mucoadhesive liposomes for intranasal immunization with an avian influenza virus vaccine in chickens. Biomaterials. 2009; 30(29): 5862-8.
8. Costa F, Hagan JE, Calcagno J, Kane M, Torgerson P, Martinez-Silveira MS, et al. Global Morbidity and mortality of leptospirosis: a systematic Review. PLoS Negl Trop Dis. 2015; 9(9): e0003898.
9. Coutinho ML, Choy HA, Kelley MM, Matsunaga J, Babbitt JT, Lewis MS, et al. A LigA three-domain region protects hamsters from lethal infection by Leptospira interrogans. PLoS Negl Trop Dis. 2011; 5(12): e1422.
10. Dellagostin OA, Grassmann AA, Hartwig DD, Felix SR, da Silva EF, McBride AJ. Recombinant vaccines against leptospirosis. Hum Vaccin. 2011; 7(11): 1215-24.
11. Dumortier H. When carbon nanotubes encounter the immune system: desirable and undesirable effects. Adv Drug Deliv Rev. 2013; 65(15): 2120-6.
12. Faisal SM, Yan W, McDonough SP, Chang YF. Leptospira immunoglobulin-like protein A variable region (LigAvar) incorporated in liposomes and PLGA microspheres produces a robust immune response correlating to protective immunity. Vaccine. 2009; 27(3): 378-87.
13. Gottardi R, Douradinha B. Carbon nanotubes as a novel tool for vaccination against infectious diseases and cancer. J Nanobiotechnology. 2013; 11: 30.
14. Hartwig DD, Bacelo KL, Oliveira PD, Oliveira TL, Seixas FK, Amaral MG, et al. Mannosylated LigANI produced in Pichia pastoris protects hamsters against leptospirosis. Curr Microbiol. 2014; 68(4): 524-30.
15. Hartwig DD, Bacelo KL, Oliveira TL, Schuch R, Seixas FK, Collares T, et al. The use of halloysite clay and carboxyl-functionalised multi-walled carbon nanotubes for recombinant LipL32 antigen delivery enhanced the IgG response. Mem Inst Oswaldo Cruz. 2015; 110(1): 134-7.
16. Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature. 1995; 374(6522): 546-9.
17. Lahoud MH, Ahmet F, Zhang JG, Meuter S, Policheni AN, Kitsoulis S, et al. DEC-205 is a cell surface receptor for CpG oligonucleotides. Proc Natl Acad Sci USA. 2012; 109(40): 16270-5.
18. Lodhi N, Mehra NK, Jain NK. Development and characterization of dexamethasone mesylate anchored on multi walled carbon nanotubes. J Drug Target. 2013; 21(1): 67-76.
19. Niyogi S, Hamon MA, Hu H, Zhao B, Bhowmik P, Sen R, et al. Chemistry of single-walled carbon nanotubes. Acc Chem Res. 2002; 35(12): 1105-13.
20. Orecchioni M, Bedognetti D, Sgarrella F, Marincola FM, Bianco A, Delogu LG. Impact of carbon nanotubes and graphene on immune cells. J Transl Med. 2014; 12: 138.
21. Palaniappan RU, McDonough SP, Divers TJ, Chen CS, Pan MJ, Matsumoto M, et al. Immunoprotection of recombinant leptospiral immunoglobulin-like protein A against Leptospira interrogans serovar Pomona infection. Infect Immun. 2006; 74(3): 1745-50.
22. Pantarotto D, Partidos CD, Graff R, Hoebeke J, Briand JP, Prato M, et al. Synthesis, structural characterization, and immunological properties of carbon nanotubes functionalized with peptides. J Am Chem Soc. 2003; 125(20): 6160-4.
23. Pantarotto D, Partidos CD, Hoebeke J, Brown F, Kramer E, Briand JP, et al. Immunization with peptide-functionalized carbon nanotubes enhances virus-specific neutralizing antibody responses. Chem Biol. 2003; 10(10): 961-6.
24. Pescatori M, Bedognetti D, Venturelli E, Menard-Moyon C, Bernardini C, Muresu E, et al. Functionalized carbon nanotubes as immunomodulator systems. Biomaterials. 2013; 34(18): 4395-403.
25. Petrovsky N, Aguilar JC. Vaccine adjuvants: current state and future trends. Immunol Cell Biol. 2004; 82(5): 488-96.
26. Prato M, Kostarelos K, Bianco A. Functionalized carbon nanotubes in drug design and discovery. Acc Chem Res. 2008; 41(1): 60-8.
27. Scheinberg DA, McDevitt MR, Dao T, Mulvey JJ, Feinberg E, Alidori S. Carbon nanotubes as vaccine scaffolds. Adv Drug Deliv Rev. 2013; 65(15): 2016-22.
28. Seixas FK, da Silva EF, Hartwig DD, Cerqueira GM, Amaral M, Fagundes MQ, et al. Recombinant Mycobacterium bovis BCG expressing the LipL32 antigen of Leptospira interrogans protects hamsters from challenge. Vaccine. 2007; 26(1): 88-95.
29. Silva EF, Medeiros MA, McBride AJ, Matsunaga J, Esteves GS, Ramos JG, et al. The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis. Vaccine. 2007; 25(33): 6277-86.
30. Silvestre BT, Rabelo EM, Versiani AF, da Fonseca FG, Silveira JA, Bueno LL, et al. Evaluation of humoral and cellular immune response of BALB/c mice immunized with a recombinant fragment of MSP1a from Anaplasma marginale using carbon nanotubes as a carrier molecule. Vaccine. 2014; 32(19): 2160-6.
31. Stefani D, Paula AJ, Vaz BG, Silva RA, Andrade NF, Justo GZ, et al. Structural and proactive safety aspects of oxidation debris from multiwalled carbon nanotubes. J Hazard Mater. 2011; 189(1-2): 391-6.
32. Thakare VS, Das M, Jain AK, Patil S, Jain S. Carbon nanotubes in cancer theragnosis. Nanomedicine. 2010; 5(8): 1277-301.
33. Tu X, Manohar S, Jagota A, Zheng M. DNA sequence motifs for structure-specific recognition and separation of carbon nanotubes. Nature. 2009; 460(7252): 250-3.
34. Vollmer J, Krieg AM. Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists. Adv Drug Deliv Rev. 2009; 61(3): 195-204.
35. Yandar N, Pastorin G, Prato M, Bianco A, Patarroyo ME, Lozano JM. Immunological profile of a Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium berghei mouse model. Vaccine. 2008; 26(46): 5864-73.
36. Yang ST, Luo J, Zhou Q, Wang H. Pharmacokinetics, metabolism and toxicity of carbon nanotubes for biomedical purposes. Theranostics. 2012; 2(3): 271-82.
37. Zanello LP, Zhao B, Hu H, Haddon RC. Bone cell proliferation on carbon nanotubes. Nano lett. 2006; 6(3): 562-7.
38. Zeinali M, Jammalan M, Ardestani SK, Mosaveri N. Immunological and cytotoxicological characterization of tuberculin purified protein derivative (PPD) conjugated to single-walled carbon nanotubes. Immunol Lett. 2009; 126(1-2): 48-53.
39. Zhao W, Tong B, Shi J, Pan Y, Shen J, Zhi J, et al. Fabrication and optoelectronic properties of novel films based on functionalized multiwalled carbon nanotubes and (phthalocyaninato)ruthenium(II) via coordination bonded layer-by-layer self-assembly. Langmuir. 2010; 26(20): 16084-9.